<DOC>
	<DOCNO>NCT01117857</DOCNO>
	<brief_summary>The primary objective study determine eight-week intervention duloxetine significantly reduce depressive symptom symptomatic menopausal woman . It hypothesize eight-week trial duloxetine promote significant improvement depression symptom menopausal woman . The secondary aim study examine eight-week intervention duloxetine significantly reduce vasomotor symptom symptomatic menopausal woman . It hypothesize eight-week trial duloxetine promote significant improvement vasomotor symptom menopausal woman .</brief_summary>
	<brief_title>Duloxetine Menopausal Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Women age 40 year old old Menopausal symptom least 3 month duration , include irregular period and/or hot flush Minimum score 15 Hamilton Rating Scale Depression ( 17item ) , Patients meet criterion major depressive episode , verify use Mini International Neuropsychiatric Interview ( MINI ) . Subjects able treated outpatient basis , Subjects able provide write informed consent Subjects presently take antidepressant medication , Subjects currently use hormone replacement therapy , Other Axis I disorder , except Generalized Anxiety Disorder Panic Disorder , accord Mini International Neuropsychiatric Interview ( MINI ) `` uncontrolled '' narrow angle glaucoma know hypersensitivity duloxetine inactive ingredient treatment monoamine oxidase inhibitor ( MAOI ) within 14 day randomization potential need use MAOI study within 5 day discontinuation study drug . Presence psychotic symptom , History mania hypomania , HAMD suicide item score &gt; 3 , End stage renal disease severe renal impairment Abnormal uterine bleeding ( heavy prolong uterine bleeding , menstrual period occur frequently every 3 week , bleed sexual intercourse , spot period ) evaluate gynecologist . Subjects serious unstable medical illness , include alcohol substance abuse , cardiovascular , hepatic , respiratory , endocrine , neuralgic , hematologic disease , history seizure disorder Subjects take medication may interact duloxetine</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>